Retinal vein occlusion ( RVO ) causes significant visual loss in patients with medical diseases especially systemic hypertension . Centrally involving macular edema is the main cause of loss of vision in such patients . previous treatment strategies for macular edema involve argon laser retinal photocoagulation , Radial optic neurotomy, intravitreal injections of steroids but recently the introduction of anti-vascular endothelial growth factor medications represents a breakthrough and has revolutionized the treatment of retinal vein occlusion associated macular edema in addition to the beneficial effect of suppressing the risky retinal neovascularization . Ranibizumab ( Lucentis ) is one of the most commonly used Anti-VEGF drugs in treatment of macular edema associated with retinal vein occlusion RVO whether the central type ( CRVO ) or the branch type ( BRVO ) .

Book Details:

ISBN-13:

978-3-330-85495-6

ISBN-10:

3330854952

EAN:

9783330854956

Book language:

English

By (author) :

Mahmoud Abdel-Radi Abdel-Salam

Number of pages:

100

Published on:

2017-06-08

Category:

Medicine